NO20032390D0 - Serotonerge midler - Google Patents

Serotonerge midler

Info

Publication number
NO20032390D0
NO20032390D0 NO20032390A NO20032390A NO20032390D0 NO 20032390 D0 NO20032390 D0 NO 20032390D0 NO 20032390 A NO20032390 A NO 20032390A NO 20032390 A NO20032390 A NO 20032390A NO 20032390 D0 NO20032390 D0 NO 20032390D0
Authority
NO
Norway
Prior art keywords
serotonergic agents
serotonergic
agents
Prior art date
Application number
NO20032390A
Other languages
English (en)
Other versions
NO325501B1 (no
NO20032390L (no
Inventor
Michael Gerard Kelly
Wayne Everett Childers
Sharon Joy Rosenzweig-Lipson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20032390D0 publication Critical patent/NO20032390D0/no
Publication of NO20032390L publication Critical patent/NO20032390L/no
Publication of NO325501B1 publication Critical patent/NO325501B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20032390A 2000-11-28 2003-05-27 Piperazinforbindelser, anvendelse og fremstilling derav, samt farmasoytisk preparat. NO325501B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25330100P 2000-11-28 2000-11-28
US29781401P 2001-06-13 2001-06-13
PCT/US2001/043160 WO2002044142A2 (en) 2000-11-28 2001-11-27 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders

Publications (3)

Publication Number Publication Date
NO20032390D0 true NO20032390D0 (no) 2003-05-27
NO20032390L NO20032390L (no) 2003-07-22
NO325501B1 NO325501B1 (no) 2008-05-26

Family

ID=26943115

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032390A NO325501B1 (no) 2000-11-28 2003-05-27 Piperazinforbindelser, anvendelse og fremstilling derav, samt farmasoytisk preparat.

Country Status (25)

Country Link
US (3) US6469007B2 (no)
EP (1) EP1339406B1 (no)
JP (1) JP4198989B2 (no)
KR (1) KR100835552B1 (no)
CN (1) CN100352437C (no)
AR (1) AR035603A1 (no)
AT (1) ATE269078T1 (no)
AU (2) AU2002237654B2 (no)
BR (1) BR0115609A (no)
CA (1) CA2428039C (no)
DE (1) DE60103927T2 (no)
DK (1) DK1339406T3 (no)
EA (1) EA005925B1 (no)
ES (1) ES2222401T3 (no)
HK (1) HK1057864A1 (no)
HU (1) HUP0400551A2 (no)
IL (1) IL156098A0 (no)
MX (1) MXPA03004677A (no)
NO (1) NO325501B1 (no)
NZ (1) NZ526150A (no)
PL (1) PL363219A1 (no)
PT (1) PT1339406E (no)
TR (1) TR200401546T4 (no)
TW (1) TWI224102B (no)
WO (1) WO2002044142A2 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432826B1 (en) * 1999-11-29 2002-08-13 Applied Materials, Inc. Planarized Cu cleaning for reduced defects
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
EP2036547A3 (en) 2001-07-20 2009-12-23 Psychogenics Inc. Treatment for Attention-Deficit Hyperactivity Disorder
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
RU2315044C2 (ru) 2002-03-12 2008-01-20 Уайт Способ получения хиральных 1,4-дизамещенных пиперазинов
CN1304388C (zh) 2002-03-12 2007-03-14 惠氏公司 合成手性n－芳基哌嗪的方法
GB0219961D0 (en) * 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
WO2004082686A2 (en) * 2003-03-13 2004-09-30 Dynogen Pharmaceuticals, Inc. Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
PA8626301A1 (es) * 2004-03-19 2006-12-07 Wyeth Wyeth Proceso para preparar derivados de n-aril-piperazina
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
KR100646337B1 (ko) * 2004-06-30 2006-11-23 주식회사 롯데기공 보일러의 누수 감지방법
EP2218736A1 (en) * 2004-10-15 2010-08-18 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Implant coated with multi-domain amphipathic helical peptides and methods of their use
RU2007131044A (ru) * 2005-03-01 2009-04-10 Вайет (Us) Кристаллический и аморфный 4-циано-n {(2r)-2-[4-(2,3-дигидробензо-[1,4]диоксин-5-ил)пиперазин-1-ил]пропил}-n-пиридин-2-илбензамида гидрохлорид
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
US7495111B2 (en) * 2005-06-17 2009-02-24 Wyeth Compounds useful as serotonin inhibitors and 5-HT1A agonists and antagonists
EP1993527A4 (en) * 2006-01-26 2009-08-05 Univ Rochester INHIBITION OF AMYLOID BETA PEPTIDE / RAGE INTERACTION AT BLOOD BRAIN BARRIER
TW200811144A (en) * 2006-06-09 2008-03-01 Wyeth Corp Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
TW200808740A (en) * 2006-06-09 2008-02-16 Wyeth Corp Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
AR063984A1 (es) * 2006-11-28 2009-03-04 Wyeth Corp Metabolitos de 5-fluoro-8-{4-[4-(6-metoxiquinolin-8-il)piperazin-1-il]piperidin-1-il}quinolina, metodos de preparacion, su uso en la fabricacion de medicamentos para el tratamiento de trastornos relacionados con 5-ht1a, composicion farmaceutica que los comprende, compuestos radioetiquetados derivado
TW200901974A (en) * 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
US8936787B2 (en) * 2008-04-15 2015-01-20 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Peptides promoting lipid efflux

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101722A (en) 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
GB9514901D0 (en) 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives

Also Published As

Publication number Publication date
TWI224102B (en) 2004-11-21
IL156098A0 (en) 2003-12-23
US6586436B2 (en) 2003-07-01
HK1057864A1 (en) 2004-04-23
US6469007B2 (en) 2002-10-22
DE60103927D1 (de) 2004-07-22
JP4198989B2 (ja) 2008-12-17
DE60103927T2 (de) 2005-06-23
ATE269078T1 (de) 2004-07-15
US20020107254A1 (en) 2002-08-08
WO2002044142A2 (en) 2002-06-06
AR035603A1 (es) 2004-06-16
US20030216408A1 (en) 2003-11-20
HUP0400551A2 (en) 2006-02-28
US20030022901A1 (en) 2003-01-30
CN100352437C (zh) 2007-12-05
KR20030051879A (ko) 2003-06-25
WO2002044142A3 (en) 2002-08-08
CN1477961A (zh) 2004-02-25
MXPA03004677A (es) 2003-09-05
EP1339406B1 (en) 2004-06-16
PT1339406E (pt) 2004-10-29
NO325501B1 (no) 2008-05-26
DK1339406T3 (da) 2004-09-27
AU3765402A (en) 2002-06-11
CA2428039A1 (en) 2002-06-06
PL363219A1 (en) 2004-11-15
EA200300619A1 (ru) 2003-10-30
BR0115609A (pt) 2003-11-11
NZ526150A (en) 2004-11-26
US7026320B2 (en) 2006-04-11
EP1339406A2 (en) 2003-09-03
TR200401546T4 (tr) 2004-09-21
NO20032390L (no) 2003-07-22
EA005925B1 (ru) 2005-08-25
AU2002237654B2 (en) 2005-07-28
ES2222401T3 (es) 2005-02-01
CA2428039C (en) 2011-08-09
KR100835552B1 (ko) 2008-06-09
JP2004520289A (ja) 2004-07-08

Similar Documents

Publication Publication Date Title
IS6492A (is) Ný bíarýlkarboxamíð
NO20032390L (no) Serotonerge midler
DK1265511T3 (da) Tandbørste
DE60140253D1 (de) Oreinheit
DE60112774D1 (de) Reibungsarme zahnbürste
DE60110671D1 (de) Umrichterwandler
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE60135277D1 (de) Elektrolumineszenselement
DE50011511D1 (de) Blowby-Heizung
DE60130359D1 (de) Deshalogenverbindungen
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
NO20011799L (no) Magnesiumdesulfureringsmiddel
AR027931A1 (es) Antitranspirantes
AR027982A1 (es) Aril- y heteroarilsulfonatos
NO20024689D0 (no) Gelemballeringstape
DE60100172D1 (de) Abisolierzange
AT500246B8 (de) Chokerring
DE60110550D1 (de) Deichsel
FI4651U1 (fi) Kaivo
FI20001398A (fi) Kaivo
FR2817889B1 (fr) Coffrage
ATA19392000A (de) Kippflügelflugzeug
ATA11602000A (de) Sonnenstandsnachführungssystem
ATA12252000A (de) Regensinkkasten
DK1274710T3 (da) Hidtil ukendte heteroaryl-diazabicycloalkaner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees